You are here

Home

Clinical Trials: Wounds and Injuries

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, March 23, 2021 - 12:00
Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC in AIS-A Level of Sub-acute SCI
Conditions:   Spinal Cord Injury, Acute;   Spinal Cord Injury at C4 Level With Complete Lesion;   Spinal Cord Injury at C5-C7 Level With Complete Lesion
Intervention:   Biological: Neural precursor cells derived from human embryonic stem cell line
Sponsors:   S.Biomedics Co., Ltd.;   Linical Co., Ltd.;   Yonsei University
Not yet recruiting
Posted: Monday, December 21, 2020 - 12:00
Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients
Condition:   Cell- and Tissue-Based Therapy
Interventions:   Biological: Amnion only;   Biological: Amnion - endometrium cells;   Biological: Amnion - amnion epithelial cells;   Biological: Amnion-EnSC-AESC
Sponsor:   Indonesia University
Recruiting
Posted: Tuesday, November 3, 2020 - 12:00
Clinical Study to Evaluate Efficacy and Safety of ASC(Autologous Adipose-derived Stem Cells) and Fibringlue or Fibringlue in Patients With Crohn's Fistula
Condition:   Crohn's Fistula
Interventions:   Biological: ASC(Autologous Adipose-derived Mesenchymal Stem Cells);   Drug: Fibringlue
Sponsor:   Anterogen Co., Ltd.
Recruiting
Posted: Tuesday, September 29, 2020 - 12:00
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle Sheet
Sponsor:   Anterogen Co., Ltd.
Recruiting
Posted: Friday, September 4, 2020 - 12:00
Mesenchymal Stem Cell-derived Pleiotropic Factor in the Treatment of Poor Healing of Postoperative Incision
Condition:   MSCs Derived Pleiotropic Factors in Treating Poorly Healed Wounds
Intervention:   Biological: The pleiotropic factor derived from mesenchymal stem cells
Sponsors:   Chinese PLA General Hospital;   Gansu Provincial Maternity and Child-Care Hospital
Not yet recruiting
Posted: Wednesday, September 2, 2020 - 12:00
Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Condition:   MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries
Interventions:   Biological: MSCs Derived Pleiotropic Factors;   Other: physiological saline
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Monday, August 31, 2020 - 12:00
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Conditions:   Trauma;   Adult Stem Cells
Interventions:   Biological: MultiStem;   Biological: Placebo
Sponsors:   Athersys, Inc;   Memorial Hermann Hospital;   United States Department of Defense
Not yet recruiting
Posted: Thursday, August 27, 2020 - 12:00
Autologous Bone Marrow-derived Mononuclear Cells for Acute Spinal Cord Injury
Condition:   Spinal Cord Injury
Interventions:   Biological: Autologous bone marrow-derived mononuclear cells;   Drug: Placebo
Sponsor:   Shanghai Changzheng Hospital
Not yet recruiting
Posted: Thursday, August 20, 2020 - 12:00
Autologous Adipose Derived Mesenchymal Stem Cells for Spinal Cord Injury Patients
Conditions:   Spinal Cord Injuries;   Paralysis
Interventions:   Other: Best Medical Management: Occupational and Physical Therapy;   Biological: Autologous, Adipose Derived Mesenchymal Stem Cells
Sponsor:   Allan Dietz
Recruiting
Posted: Tuesday, August 4, 2020 - 12:00
Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers
Condition:   Diabetic Foot Ulcer
Intervention:   Biological: ALLO-ASC-SHEET
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting

Pages